Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Ovarian Neoplasms

Free Subscription 04.05.2025 1 BMC Cancer 1 Br J Cancer 2 Cancer Res 1 Curr Opin Obstet Gynecol 2 Eur J Obstet Gynecol Reprod Biol 2 Gynecol Oncol 1 Int J Gynaecol Obstet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. STOER NC, Botteri E, Lindemann K, Langseth H, et al
   Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway.
   BMC Cancer. 2025;25:807.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. TREWIN-NYBRATEN CB, Leithe S, Paulsen T, Langseth H, et al
   Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway.
   Br J Cancer. 2025 Apr 26. doi: 10.1038/s41416-025-03018.
   PubMed         Abstract available
   
   

   
   Cancer Res

3. HOCKINGS H, Lakatos E, Huang W, Mossner M, et al
   Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control.
   Cancer Res. 2025 Apr 29. doi: 10.1158/0008-5472.CAN-25-0351.
   PubMed         Abstract available
   
   
4. LAWSON-MICHOD KA, Marks JR, Collin LJ, Nix DA, et al
   Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals.
   Cancer Res. 2025 Mar 10. doi: 10.1158/0008-5472.CAN-24-1879.
   PubMed         Abstract available
   
   

   
   Curr Opin Obstet Gynecol

5. SAFI LA, Al-Safi ZA
   Fertility counseling for patients with hereditary breast and ovarian cancer syndrome.
   Curr Opin Obstet Gynecol. 2025 Apr 30. doi: 10.1097/GCO.0000000000001038.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

6. SHI G, Wang C, Lu Y, Zhang P, et al
   Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei originating from ovarian teratomas: A single-center case series and literature review.
   Eur J Obstet Gynecol Reprod Biol. 2025;309:107-112.
   PubMed         Abstract available
   
   
7. DITTO A, Fucina S, Chiarello G, Bogani G, et al
   An effective surgical approach to treat obese patients with gynecological disease using a subcutaneous abdominal wall-retraction device to perform low-pressure laparoscopy: A prospective, single-center study.
   Eur J Obstet Gynecol Reprod Biol. 2025;309:55-60.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

8. POVEDA A, Lheureux S, Colombo N, Cibula D, et al
   Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial.
   Gynecol Oncol. 2025;197:74-82.
   PubMed         Abstract available
   
   
9. YOU B, Anderson C, Cecere SC, Carrot A, et al
   Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial.
   Gynecol Oncol. 2025;197:66-73.
   PubMed         Abstract available
   
   

   
   Int J Gynaecol Obstet

10. VARGHESE S, Lim MC, Armbrust R, Pareja R, et al
    Worldwide barriers of optimal surgical care provision in advanced ovarian cancer.
    Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70033.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.